Medicare Enrolled
Dr. John Lucas, MD
Family Medicine · Graham, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lucas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lucas? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lucas
Dr. John Lucas is a family medicine in Graham, TX, with 20 years in practice. Based on federal Medicare data, Dr. Lucas performed 19,830 Medicare services across 5,952 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lucas received a total of $4,310 from 43 pharmaceutical and/or device companies across 297 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lucas is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 0% volume in TX$ $4,310 industry payments
Medicare Practice Summary
Medicare Utilization ↗19,830
Medicare services
Top 0% in TX for family medicine
5,952
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~992 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Allergy immunotherapy preparation | 4,020 | $11 | $125 |
| Denosumab injection (Prolia/Xgeva) | 2,940 | $18 | $30 |
| Office visit, established patient (30-39 min) | 1,374 | $85 | $250 |
| Blood draw (venipuncture) | 887 | $8 | $20 |
| Basic metabolic blood panel | 779 | $8 | $60 |
| Chronic care management, first 20 min/month | 749 | $47 | $122 |
| Complete blood count (CBC) with differential | 687 | $8 | $40 |
| Liver function blood test panel | 674 | $8 | $85 |
| Office visit, established patient (20-29 min) | 583 | $58 | $170 |
| Lipid panel (cholesterol and triglycerides) | 561 | $13 | $100 |
| Allergy skin test | 560 | $3 | $30 |
| Hemoglobin A1c test (diabetes monitoring) | 491 | $10 | $60 |
| Test for allergy using allergenic extract injected into skin | 414 | $6 | $35 |
| Allergy injection therapy, multiple injections | 390 | $8 | $45 |
| Annual alcohol misuse screening, 5 to 15 minutes | 303 | $18 | $53 |
| Advance care planning consultation, first 30 min | 302 | $78 | $253 |
| Annual depression screening | 293 | $18 | $75 |
| Annual wellness visit, follow-up | 290 | $124 | $275 |
| Destruction of precancerous skin growths, 2-14 | 263 | $4 | $35 |
| Infectious disease DNA/RNA test | 217 | $34 | $100 |
| Drug injection, under skin or into muscle | 203 | $9 | $55 |
| Remote patient monitoring management, 20 min/month | 198 | $37 | $149 |
| Dexamethasone injection (steroid) | 160 | $0 | $5 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 153 | $78 | $125 |
| Ceftriaxone antibiotic injection | 153 | $0 | $5 |
| Urinalysis with microscopic exam | 129 | $3 | $35 |
| Chest X-ray, 2 views | 117 | $22 | $95 |
| Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique | 108 | $34 | $100 |
| Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique | 108 | $34 | $100 |
| Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | 108 | $140 | $1,100 |
| Chronic care management, additional 20 min/month | 108 | $36 | $94 |
| 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 108 | $50 | $100 |
| Natriuretic peptide (heart and blood vessel protein) level | 98 | $38 | $200 |
| Bone density scan (DEXA) | 94 | $36 | $335 |
| Destruction of precancerous skin growth, 1 | 91 | $43 | $192 |
| Electrocardiogram (EKG), 12-lead | 90 | $10 | $75 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 87 | $30 | $122 |
| Remote patient monitoring device, 30 days | 85 | $37 | $177 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 77 | $16 | $45 |
| Betamethasone steroid injection | 68 | $4 | $25 |
| Prothrombin time test (blood clotting) | 67 | $4 | $35 |
| Steroid injection (triamcinolone) | 57 | $1 | $10 |
| Echocardiogram, transthoracic | 54 | $131 | $608 |
| Office visit, established patient (10-19 min) | 49 | $37 | $100 |
| Ultrasound study of arm and leg arteries | 44 | $46 | $246 |
| Ultrasound of aorta, vena cava, groin vessels or bypass grafts | 44 | $75 | $351 |
| Ultrasound of heart, follow-up | 43 | $49 | $800 |
| Test to measure expiratory airflow and volume | 42 | $20 | $103 |
| X-ray of abdomen, 2 views | 40 | $24 | $104 |
| Comprehensive metabolic blood panel | 35 | $10 | $70 |
| Joint injection, major joint | 26 | $49 | $180 |
| Transitional care management services for problem of high complexity | 23 | $211 | $520 |
| X-ray of lower and sacral spine, 2-3 views | 22 | $26 | $110 |
| X-ray of knee, 1-2 views | 20 | $19 | $97 |
| Office visit, established patient, complex (40-54 min) | 20 | $138 | $335 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 19 | $4 | $40 |
| Urinalysis, manual | 16 | $3 | $20 |
| Transitional care management services for problem of at least moderate complexity | 16 | $156 | $543 |
| Foot X-ray, 3+ views | 15 | $24 | $95 |
| Removal of impacted ear wax | 14 | $31 | $140 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $332 | $1,382 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 11 | $47 | $350 |
| Ultrasound of one side of head and neck blood flow | 11 | $83 | $373 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 11 | $127 | $580 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
20.8% medium
78.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,310
Total received (2018-2024)
Avg $616/year across 7 years
Top 15% in TX for family medicine
43
Companies
297
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,277 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$33 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$892
2023$859
2022$276
2021$173
2020$264
2019$696
2018$1,150
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$511
Novartis Pharmaceuticals Corporation
$372
GlaxoSmithKline, LLC.
$345
PFIZER INC.
$312
AstraZeneca Pharmaceuticals LP
$301
Lilly USA, LLC
$260
Astellas Pharma US Inc
$207
Allergan Inc.
$192
Teva Pharmaceuticals USA, Inc.
$186
Janssen Pharmaceuticals, Inc
$178
Amgen Inc.
$177
ABBVIE INC.
$156
Galderma Laboratories, L.P.
$142
Sunovion Pharmaceuticals Inc.
$123
Boehringer Ingelheim Pharmaceuticals, Inc.
$116
Merck Sharp & Dohme Corporation
$51
IDORSIA PHARMACEUTICALS US INC
$46
Takeda Pharmaceuticals U.S.A., Inc.
$44
Xeris Pharmaceuticals, Inc.
$44
SANOFI-AVENTIS U.S. LLC
$43
Bayer HealthCare Pharmaceuticals Inc.
$34
Bayer Healthcare Pharmaceuticals Inc.
$33
Tactile Systems Technology Inc
$33
Exact Sciences Corporation
$32
Mylan Specialty L.P.
$32
E.R. Squibb & Sons, L.L.C.
$31
REVANCE THERAPEUTICS, INC.
$27
Amarin Pharma Inc.
$22
Gilead Sciences, Inc.
$22
Genentech USA, Inc.
$21
Corium, LLC
$20
Allergan, Inc.
$20
Ferring Pharmaceuticals Inc.
$19
BOSTON SCIENTIFIC CORPORATION
$19
Digirad Corporation
$18
Ethicon US, LLC
$18
Paratek Pharmaceuticals, Inc.
$17
Sumitomo Pharma America, Inc.
$17
Celgene Corporation
$15
Supernus Pharmaceuticals, Inc.
$14
Abbott Laboratories
$14
Upsher-Smith Laboratories LLC
$13
Flexion Therapeutics, Inc.
$11
Top 3 companies account for 28.5% of total payments
Associated products mentioned in payments ›
AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AUSTEDO · AZSTARYS · Aimovig · Amitiza · Austedo XR · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BREZTRI · BROVANA · BYSTOLIC · CHANTIX · Cardius 3m · Cologuard Collection Kit · DAXXIFY · ELIQUIS · ENTRESTO · EUCRISA · EUFLEXXA · EVENITY · EVUSHELD · FARXIGA · FLUMIST QUADRIVALENT · FREESTYLE LIBRE · Flexitouch Plus · GEMTESA · GVOKE PFS · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINX Reflux Management System · LINZESS · LONHALA MAGNAIR · LYRICA · MOUNJARO · Myrbetriq · NURTEC ODT · NUZYRA · Otezla · Ozempic · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · QELBREE · QUVIVIQ · RECORLEV · Repatha · Rybelsus · SHINGRIX · SOLIQUA · STIOLTO RESPIMAT · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRELEGY ELLIPTA · TRULICITY · TRUMENBA · Tresiba · Trintellix · UBRELVY · Utibron · VIBERZI · VRAYLAR · Vascepa · Veozah · Vesicare · Victoza · WATCHMAN · XARELTO · Xofluza · YUPELRI · Yupelri · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $22 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
17
Per 100K population
94.6
County median income
$63,723
Nearest hospital
GRAHAM REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lucas is a clinical cardiology specialist, with above-average Medicare volume (top 0% in TX), and high industry engagement (low-engagement, top 15%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lucas experienced with allergy immunotherapy preparation?
Based on Medicare claims data, Dr. Lucas performed 4,020 allergy immunotherapy preparation services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lucas receive payments from pharmaceutical companies?
Yes. Dr. Lucas received a total of $4,310 from 43 companies across 297 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lucas's costs compare to other family medicines in Graham?
Dr. Lucas's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lucas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Graham
Browse family medicines in Graham ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in TX
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in TX
Which TX family medicines receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology